Last updated on May 2020

A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate High or Very High Risk Myelodysplastic Syndrome (MDS).


Find a site near you

Start Over

Highlands Oncology Group

Fayetteville, AR United States
1.18miles
  Connect »

Novartis Investigative Site

Fayetteville, AR United States
1.18miles
  Connect »

Highlands Oncology Group

Fayetteville, AR United States
7.85miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.